Atrial Fibrillation Research for Cancer Patients

Atrial Fibrillation in Active Cancer Patients

Recruiting Observational Study
Cancer Drug Toxicity Atrial Fibrillation Cardiovascular Complication
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
University Hospital, Caen · Other
Who this trial is looking for

This trial is looking for adult patients who have cancer and have experienced atrial fibrillation. Participants will be monitored for major heart events over a year.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am an adult patient
  • I have been diagnosed with cancer in the last 6 months
  • I have had at least one episode of atrial fibrillation
  • I was in sinus rhythm when my cancer was diagnosed

You may not be able to join if

  • I am receiving palliative care
  • I have a history of long-standing atrial fibrillation
  • My doctors expect me to die within a month after my atrial fibrillation

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Atrial fibrillation is a common complication of both cancer and anticancer drugs but the consequences of such events remain poorly known and are not adressed in both phase III oncological trials and cardiological guidelines. The objective of this study is to create a prospective multicenter international registry of adult patients with an active cancer and experiencing atrial fibrillation to study…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * adult patients * outpatients or hospitalized patients * with a confirmed cancer (other than basal-cell or squamous-cell carcinoma of the skin, primary brain tumor, known intracerebral metastases, or acute leukemia) and an active cancer (defined as cancer that had been diagnose…
Contacts

Joachim Alexandre, MD, PhD

+330231064770

alexandre-j@chu-caen.fr

CONTACT